PARIS - Innate Pharma SAS and the Danish pharmaceutical company Novo Nordisk A/S entered into a strategic partnership to develop new drugs targeting natural killer (NK) cells for the treatment of cancer, autoimmune disorders and infectious diseases. (BioWorld International)